A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2002
10/16/2002	EP1248792A1 Antisense modulation of peroxisome proliferator-activated receptor gamma expression
10/16/2002	EP1248791A1 Antisense modulation of caspase 3 expression
10/16/2002	EP1248787A2 Novel subtituted pyrazolo[4, 3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them
10/16/2002	EP1248785A1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
10/16/2002	EP1248768A1 Bile acid-substituted phenyl-alkenoylguanidines, method for producing said phenyl-alkenoylguanidines, use thereof as medicaments or diagnostic reagents and medicaments containing the same
10/16/2002	EP1248646A2 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen
10/16/2002	EP1248632A2 Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP1248607A1 Urotensin-ii receptor antagonists
10/16/2002	EP1248603A2 Use of particular compounds for prophylaxis and treatment of hepatitis c
10/16/2002	EP1248599A1 Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
10/16/2002	EP1248595A1 Multi-step drug dosage forms
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP1140065A4 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/16/2002	EP0991653B1 Novel compounds
10/16/2002	EP0944385B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith
10/16/2002	EP0941108B1 Wound healing and treatment of fibrosis
10/16/2002	EP0927161B1 Substituted cyclic amine metalloprotease inhibitors
10/16/2002	EP0906273B1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
10/16/2002	EP0844881B1 Laxative comprising lactitol and psyllium
10/16/2002	EP0637976B2 Medicament for disinfection of the oral cavity
10/16/2002	EP0619742B1 Transfection of lung via aerosolized transgene delivery
10/16/2002	CN1374968A 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, method fo r producing the same, medicaments containing these compounds and their use
10/16/2002	CN1374967A Compounds for the treatment of ischemia
10/16/2002	CN1374966A 嘌呤衍生物 Purine derivatives
10/16/2002	CN1374962A 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives
10/16/2002	CN1374956A 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof and their use as anticonvulsants
10/16/2002	CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
10/16/2002	CN1374953A Aromatic nitrogenous six-membered ring compounds
10/16/2002	CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors
10/16/2002	CN1374863A Bicyclic antagonists selective for the alpha beta integrin
10/16/2002	CN1374859A 药物粉剂 Drug powder
10/16/2002	CN1374858A For mulations for parenteral use of estramustine phosphate with improved pharmacological properties
10/16/2002	CN1374857A Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins
10/16/2002	CN1374129A Kidney-invigorating, vital energy-benefiting and blood nourishing oral liquor and its compounding process
10/16/2002	CN1374125A Chinese medicine for treating gastric ulcer and gastric perforation
10/16/2002	CN1374124A Chinese herbal medicine composition for treating pyloric spirobacterium infected gastropathy and its production process
10/16/2002	CN1374120A Pseudozoogloea adjuvant and its prepn and application
10/16/2002	CN1374117A Chinese medicine for treating intractable headache and dizziness and its prepn process
10/16/2002	CN1374115A Pancreatitis treating oral medicine and its prepn
10/16/2002	CN1374106A Chinese medicine prepn for treating hepatitis B and its prepn process
10/16/2002	CN1374101A Kidney benefiting belt
10/16/2002	CN1374099A Liver fat eliminating capsule and its production process
10/16/2002	CN1374090A Application of active biologics prepared with spinal cord, brains, liver and blood of turtle and/or tortoise and animal penis in preparing medicine
10/16/2002	CN1092656C Kinetic oxidaizoles
10/16/2002	CN1092652C 2-imidazolinylaminoindole compound and composition containing the same use
10/16/2002	CN1092642C Quinoline derivatives as tachykinin NK 3 receptor antagonists
10/16/2002	CN1092640C Imides as PDE III, PDE IV and TNF inhibitors
10/16/2002	CN1092520C Ecological enema liquid for curing functional constipation
10/15/2002	USRE37886 4-(1-(3,5bis(trifluoromethyl) benzoyl)-2-(phenylmethyl)-4-piperidinyl)-n-(2,6dimethylphenyl)-1-piperazine acetamide, having tachykinin and substance p antagonistic activity; analgesic and antiinflammatory agents
10/15/2002	US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/15/2002	US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002	US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002	US6465507 Antitumor agents
10/15/2002	US6465505 Benzyl-substituted benzimidazoles
10/15/2002	US6465497 Arylthiazolidinedione derivatives
10/15/2002	US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002	US6465489 Such as 1-benzoyl-3-(3,4-dichlorophenyl)-3-(3-(4-(n',n'-dimethylureido)-4 -phenylpiperidin-1-)propyl)piperidine; psychiatric and psychosomatic illnesses, hypertension, central or peripheral pathology
10/15/2002	US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/15/2002	US6465471 Cinnamic acid derivatives
10/15/2002	US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002	US6465461 5-amino-6-(2,3,5-trichlorophenyl)-1,2,4-triazine; potent, selective anticonvulsant; dihydrofolate reductase inhibitor; analgesics; epilepsy, bipolar disorder, pain
10/15/2002	US6465458 Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
10/15/2002	US6465444 Protein tyrosine phosphatases(ptp-1b); antidiabetic, antitumor and anorexigenic agents; combination therapy
10/15/2002	US6465440 Antimutagenic compositions for treatment and prevention of photodamage to skin
10/15/2002	US6465437 Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
10/15/2002	US6465435 Prevention and/or treatment of antibiotic associated diarrhea or pseudomembranous colitis; binding and eliminating toxins a and b from gastrointestinal tract using oligosaccharide sequence attached to inert support by nonpetidyl linker
10/15/2002	US6465424 Comprising a purified polypeptide the amino acid sequence of which comprises the pre-activation domain from plasminogen and at least one kringle from plasminogen
10/15/2002	US6465187 Inhibition of gene expression of antiapoptotic genes to treat mast cell mediated inflammatory disorders
10/15/2002	US6465003 Drug delivery
10/15/2002	US6464997 Mutualistic combination of said spirulina platensis powder and fungus selected from the phylum basideomnycota; pesticidal agent
10/15/2002	US6464987 Pharmaceutical compositions capable of being gelled
10/15/2002	US6464963 Desensitizing dentifrice containing potassium and tin salts
10/15/2002	CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
10/15/2002	CA2191837C Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
10/15/2002	CA2145211C The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
10/15/2002	CA2091766C Enhancement of glutathione levels with glutamine
10/10/2002	WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
10/10/2002	WO2002079448A2 G-protein coupled receptors
10/10/2002	WO2002079441A2 Secreted proteins
10/10/2002	WO2002079408A2 Short bioactive peptides and methods for their use
10/10/2002	WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002	WO2002079262A1 Composition for enteral nutrition comprising fibres
10/10/2002	WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002	WO2002079248A2 Mammalian alpha-helical protein-53
10/10/2002	WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002	WO2002079236A1 Alpha conotoxin peptides with analgesic properties
10/10/2002	WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002	WO2002079195A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/10/2002	WO2002079194A1 Ccr5 antagonists useful for treating aids
10/10/2002	WO2002079189A2 Spiroisoquinoline compounds, methods for their preparation and intermediates
10/10/2002	WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002	WO2002079175A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
10/10/2002	WO2002079170A2 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing them
10/10/2002	WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002	WO2002079162A1 Carboxylic acids
10/10/2002	WO2002079157A1 Aryl oxime-piperazines useful as ccr5 antagonists
10/10/2002	WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002	WO2002079155A1 Pyrrolidine sulfonamides
10/10/2002	WO2002079154A1 Substituted carbazoles as inhibitors of spla2

1 ... 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 ... 1258